Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.

Autor: Sculier, J-P, Lafitte, J-J, Paesmans, M, Thiriaux, J, Alexopoulos, C G, Baumöhl, J, Schmerber, J, Koumakis, G, Florin, M C, Zacharias, C, Berghmans, T, Mommen, P, Ninane, V, Klastersky, J
Zdroj: British Journal of Cancer. 11/1/2000, Vol. 83 Issue 9, p1128. 8p.
Databáze: Academic Search Ultimate